H3R is involved in cognitive function, and its antagonism is associated with the therapeutic outcomes of conditions, such as attention deficit hyperactivity disorder (ADHD), schizophrenia, Alzheimer's disease, and narcolepsy12. This evidence concerns the gene HRH3 and attention deficit-hyperactivity disorder.